COVID-19 Research Paper Volume 13, Issue 20 pp 23442—23458

Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019

Timeline of events for 196 COVID-19 patients with hyperamylasemia. Amylase level at the termination time was extracted within 5 days before discharge or death, and 67 patients with no available data.

Figure 5. Timeline of events for 196 COVID-19 patients with hyperamylasemia. Amylase level at the termination time was extracted within 5 days before discharge or death, and 67 patients with no available data.